Login Register Cart 0
Generic placeholder image

Current Respiratory Medicine Reviews

Editor-in-Chief

ISSN (Print): 1573-398X
ISSN (Online): 1875-6387

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Editorial

Solitary Lung Nodule: To Ablate or not to Ablate?

Author(s): Adela Bazbaz, Francesca Martinez and Joseph Varon

Volume 21, Issue 3, 2025

Published on: 20 January, 2025

Page: [189 - 190] Pages: 2

DOI: 10.2174/1573398X2103250120143602

Next »
[1]
Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2024; 74(3): 229-63.
[http://dx.doi.org/10.3322/caac.21700]
[2]
Cruickshank A, Stieler G, Ameer F. Evaluation of the solitary pulmonary nodule. Intern Med J 2019; 49(3): 306-15.
[http://dx.doi.org/10.1111/imj.14163]
[3]
Howlader N, Forjaz G, Mooradian MJ, et al. The effect of advances in lung-cancer treatment on population mortality. N Engl J Med 2020; 383(7): 640-9.
[http://dx.doi.org/10.1056/NEJMoa1916623]
[4]
Gould MK, Tang T, Liu ILA, et al. Recent trends in the identification of incidental pulmonary nodules. Am J Respir Crit Care Med 2015; 192(10): 1208-14.
[http://dx.doi.org/10.1164/rccm.201505-0990OC]
[5]
Mazzone PJ, Lam L. Evaluating the patient with a pulmonary nodule. JAMA 2022; 327(3): 264.
[http://dx.doi.org/10.1001/jama.2021.24133]
[6]
Patel PP, Duong DK, Mahajan AK, Imai TA. Single-setting robotic lung nodule diagnosis and resection. Thorac Surg Clin 2023; 33(3): 233-44.
[http://dx.doi.org/10.1016/j.thorsurg.2023.03.001]
[7]
Quirk MT, Lee S, Murali N, Genshaft S, Abtin F, Suh R. Alternatives to surgery for early-stage non-small cell lung cancer. Clin Chest Med 2020; 41(2): 197-210.
[http://dx.doi.org/10.1016/j.ccm.2020.02.002]
[8]
Lencioni R, Crocetti L, Cioni R, et al. Response to radiofrequency ablation of pulmonary tumours: a prospective, intention-to-treat, multicentre clinical trial (the RAPTURE study). Lancet Oncol 2008; 9(7): 621-8.
[http://dx.doi.org/10.1016/S1470-2045(08)70164-5]
[9]
Macchi M, Belfiore MP, Floridi C, et al. Radiofrequency versus microwave ablation for treatment of lung tumours: LUMIRA (lung microwave radiofrequency) randomized trial. Med Oncol 2017; 34(5): 96.
[http://dx.doi.org/10.1007/s12032-017-0964-y]
[10]
Yang X, Jin Y, Lin Z, et al. Microwave ablation for the treatment of peripheral ground-glass nodule-like lung cancer: Long-term results from a multi-center study. J Cancer Res Ther 2023; 19(4): 1001-10.
[http://dx.doi.org/10.4103/jcrt.jcrt_967_23]
[11]
Sharma A, Abtin F, Shepard JAO. Image-guided ablative therapies for lung cancer. Radiol Clin North Am 2012; 50(5): 975-99.
[http://dx.doi.org/10.1016/j.rcl.2012.06.001]
[12]
Zemlyak A, Moore WH, Bilfinger TV. Comparison of survival after sublobar resections and ablative therapies for stage I non-small cell lung cancer. J Am Coll Surg 2010; 211(1): 68-72.
[http://dx.doi.org/10.1016/j.jamcollsurg.2010.02.050]
[13]
Tada A, Hiraki T, Iguchi T, et al. Influence of radiofrequency ablation of lung cancer on pulmonary function. Cardiovasc Intervent Radiol 2012; 35(4): 860-7.
[http://dx.doi.org/10.1007/s00270-011-0305-6]
[14]
Dupuy DE, Fernando HC, Hillman S, et al. Radiofrequency ablation of stage IA non-small cell lung cancer in medically inoperable patients: Results from the American College of Surgeons Oncology Group Z4033 (Alliance) trial. Cancer 2015; 121(19): 3491-8.
[http://dx.doi.org/10.1002/cncr.29416]

Rights & Permissions Print Cite
Article Metrics
14
2
Wayfinder Image
© 2025 Bentham Science Publishers | Privacy Policy